Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2012
08/15/2012CN101489579B Prophylactic or therapeutic agent for viral disease
08/15/2012CN101432284B Dihydropyrazolopyrimidinone derivative
08/15/2012CN101307046B Tripeptidyl peptidase inhibitors
08/15/2012CN101203251B 玻璃体可视化剂 Vitreous visualization agent
08/15/2012CN101039953B Therapeutic and diagnostic agents
08/14/2012US8242281 Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands
08/14/2012US8242147 Aryl ureas with angiogenisis inhibiting activity
08/14/2012US8242146 Administering ROFLUMILAS and DICLOFENAC; antiinflammatory agents
08/14/2012US8242127 Derivatives of pyrimido[6,1-A]isoquinolin-4-one
08/14/2012US8242118 Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders
08/14/2012US8242091 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin
08/14/2012US8242090 Vascular therapeutics
08/14/2012US8242089 Sphingolipids polyalkylamine conjugates for use in transfection
08/14/2012US8242079 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
08/14/2012US8241899 Anti-TNF antibodies, compositions, methods and uses
08/14/2012US8241848 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
08/14/2012US8241674 Methods and compositions for heavy metal detoxification
08/14/2012US8241665 Chewable soft capsule
08/14/2012US8241637 DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof
08/14/2012CA2632078C Methods of inducing terminal differentiation
08/14/2012CA2514971C Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene
08/14/2012CA2497845C Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
08/14/2012CA2472021C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
08/14/2012CA2436326C Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
08/14/2012CA2429954C Method for altering cell fate
08/14/2012CA2351396C Bioengineered tissue constructs and methods for producing and using them
08/09/2012WO2012106058A2 Animal treatments
08/09/2012WO2012105635A1 2-oxy-substituted 8-oxodihydropurine derivative
08/09/2012WO2012105624A1 Transdermal patch
08/09/2012WO2012105623A1 Production method for adhesive patch
08/09/2012WO2012105622A1 Patch preparation
08/09/2012WO2012105594A1 Ring-fused heterocyclic derivative
08/09/2012WO2012105588A1 Tetrahydroisoquinoline derivative
08/09/2012WO2012105573A1 CYCLIC SULFONIUM SALT, PROCESS FOR PRODUCTION OF SAME, AND α-GLUCOSIDASE INHIBITOR COMPRISING SAME
08/09/2012WO2012105486A1 Tegafur-containing composition for single daily and alternate-day dosing
08/09/2012WO2012105467A1 Oligonucleic acid composition and antiallergic agent
08/09/2012WO2012105312A1 Arthritis prevention/amelioration substance
08/09/2012WO2012105224A1 Vaccine adjuvant
08/09/2012WO2012105219A1 Antibody therapy effect-enhancing drug
08/09/2012WO2012105130A1 Fat and oil composition for promoting insulin secretion
08/09/2012WO2012104838A1 Use of hgh for the treatment of small for gestational age infants under two years of age
08/09/2012WO2012104822A1 Combinations comprising macitentan for the treatment of glioblastoma multiforme
08/09/2012WO2012104569A1 Composition of monoterpenoids for the treatment of cancer
08/09/2012WO2012104568A1 Compositions of monoterpenoids for stimulating the immune system
08/09/2012WO2012103813A1 Danshensu and chuanxiongqin derivatives, process for preparation, and use thereof
08/09/2012WO2012103806A1 Bicyclic heteroaryl compounds as gpr119 receptor agonists
08/09/2012WO2012019113A3 Inhibitors of erk for developmental disorders of neuronal connectivity
08/09/2012US20120203162 Method for treating neovascularization
08/09/2012US20120202996 Tetrahydroquinoline derivatives
08/09/2012US20120202876 Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
08/09/2012US20120202874 Antisense oligonucleotide modulation of stat3 expression
08/09/2012US20120202830 Substituted xanthine derivatives
08/09/2012US20120202829 6-Cycloalkyl-pyrazolopyrimidinones for the Treatment of CNS Disorders
08/09/2012US20120202817 Compounds having 4-pyridylalkylthio group as a substituent
08/09/2012US20120202766 N4-acylcytosine nucleosides for treatment of viral infections
08/09/2012US20120202754 Enhanced substrates for the protease activity of serotype a botulinum neurotoxin
08/09/2012US20120202208 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
08/09/2012US20120201906 Novel medical uses for no and no donor compounds
08/09/2012US20120201897 Composition for inducing tissue regeneration by activating platelet-rich plasma (prp), and method for manufacturing same
08/09/2012US20120201790 Promoters exhibiting endothelial cell specificity and methods of using same
08/09/2012US20120201760 Metal oxide particles coated with polyethylene glycol and their synthesis
08/09/2012US20120201756 Plasma kallikrein binding proteins
08/09/2012US20120201753 Methods and compositions related to targeting wounds, regenerating tissue, and tumors
08/09/2012CA2828988A1 Bicyclic heteroaryl compounds as gpr119 receptor agonists
08/09/2012CA2828570A1 Tetrahydroisoquinoline derivative
08/09/2012CA2826356A1 Substance for preventing and improving arthritis
08/09/2012CA2826217A1 Transdermal patch
08/09/2012CA2826003A1 Patch preparation
08/09/2012CA2823994A1 Combinations comprising macitentan for the treatment of glioblastoma multiforme
08/08/2012EP2484675A1 Novel phenylpyridine derivative and medicinal agent comprising same
08/08/2012EP2484668A1 Indazole analogue
08/08/2012EP2484363A1 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-5-methylthiophene-2-carboxamide
08/08/2012EP2484361A1 Agent for reducing visceral fat weight
08/08/2012EP2484359A1 Heparanase activity inhibitor
08/08/2012EP2484355A1 Laminin-332 production stimulating composition
08/08/2012EP2190447B1 His-Pro-Gly-Ser-Arg-lle-Val-Leu-Ser-Leu-Asp-Val-Pro-lle-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-ile-Leu-Ala-Arg-Val-NH2 for use in anti-angiogenic therapy
08/08/2012EP2187901B1 Neuropeptide El optionally combined with ACTH (7-38) for use in anti-angiogenic therapy
08/08/2012EP1458399B1 Pregnane steroids for use in the treatment of cns disorders
08/08/2012EP1169038B1 Cyclic protein tyrosine kinase inhibitors
08/08/2012CN1536999B Crystalline forms
08/08/2012CN102630161A Method of slowing the aging process by activating Sirtuin enzymes with a combination of fucoxanthin and punicic acid
08/08/2012CN102627611A Polymorphic form of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one
08/08/2012CN102627610A One type of benzimidazole derivatives and application thereof
08/08/2012CN102626494A Medicine compound for treating spontaneous perspiration
08/08/2012CN102626484A Medicine compound for treating subacute thyroiditis
08/08/2012CN101941959B Application of dihydroxy-benzopyrone compounds in preparing medicaments for preventing and treating bone fracture and osteoporosis
08/08/2012CN101658527B Composition for suppressing target gene expression
08/08/2012CN101485791B Application of Ampelopsis grossedentata total flavone in preparing medicament for preventing and treating adverse reaction of tumor chemoradiotherapy
08/08/2012CN101310771B 视觉功能障碍改善剂 Visual dysfunction improving agent
08/07/2012US8236965 Benzimidazole derivatives and their use as a medicament
08/07/2012US8236947 Quinoline derivatives and their use as 5-HT6 ligands
08/07/2012US8236836 Composition comprising at least one oxazoline for inhibiting langerhans cell migration, and uses thereof
08/07/2012US8236803 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists
08/07/2012US8236774 Human telomerase catalytic subunit
08/07/2012US8236507 Modulators of TNF receptor associated factor (TRAF), their preparation and use
08/07/2012US8236351 Tamper-resistant oral opioid agonist formulations
08/07/2012US8236345 Composition and use
08/07/2012US8236339 Therapeutic delivery of carbon monoxide
08/07/2012US8236143 Controlling chemical reactions by spectral chemistry and spectral conditioning
08/07/2012US8236048 Drug/drug delivery systems for the prevention and treatment of vascular disease
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 1564